Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Fusion of cells
Reexamination Certificate
2001-01-02
2002-05-07
Ketter, James (Department: 1636)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Fusion of cells
C514S04400A, C435S458000
Reexamination Certificate
active
06383811
ABSTRACT:
FIELD OF THE INVENTION
The invention relates to compounds and methods for use in biologic systems. More particularly, polyions are utilized for modifying the charge (“recharging”) of particles, such as molecules, polymers, nucleic acids and genes for delivery to cells.
BACKGROUND
Polymers are used for drug delivery for a variety of therapeutic purposes. Polymers have also been used in research for delivery of nucleic acids (polynucleotides and oligonucleotides) to cells, the process is one step in reaching a goal of providing therapeutc processes (gene therapy). One of the several methods of nucleic acid delivery to the cells is the use of DNA-polyion complexes. It has been shown that cationic proteins like histones and protamines or synthetic polymers like polylysine, polyarginine, polyornithine, DEAE dextran, polybrene, and polyethylenimine may be effective intracellular delivery agents while small polycations like spermine are ineffective.
In terms of intravenous injection, DNA must cross the endothelial barrier and reach the parenchymal cells of interest The largest endothelia fenestrae (holes in the endothelial barrier) occur in the liver and have an average diameter from 75-150 nm. The trans-epithelial pores in other organs are much smaller, for example, muscle endothelium can be described as a structure which has a large number of small pores with a radius of 4 nm, and a very low number of large pores with a radius of 20-30 nm. The size of the DNA complexes is also important for the cellular uptake process. After binding to the target cells the DNA-polycation complex should be taken up by endocytosis.
Applicants have provided a process for delivering a compound across the endothelial barrier to the extravascular space and then to a cell.
Summary
Described in a preferred embodiment is a process for enhancing delivery of a polyion to a cell, comprising the formation of a complex of polyampholyte and polyion. Then, delivering the complex into a cell.
In another preferred embodiment, we describe a process for extravasation of a complex. The process comprises the formation of a complex of polyampholyte and polyion. Then, inserting the complex into a vessel and delivering the complex to an extravascular space.
Reference is now made in detail to the preferred embodiments of the invention, examples of which are illustrated in the accompanying drawings.
REFERENCES:
patent: 6153597 (2000-11-01), Blanche et al.
patent: 6232295 (2001-05-01), Kayyem et al.
Asayama, Shoichiro, Et al., “Synthesis of Novel Polyampholyte Comb-Type Copolymers Consisting of a Poly(L-lysine) Backbone and Hyaluronic Acid Side Chains for a DNA Carrier.”Bioconjugate Chem.; 1998; vol. 9, No. 4, pp. 476-481.
Dash, P.R., Et al., “Factors Affecting Blood Clearance and In Vivo Distribution of Polyelectrolyte Complexes for Gene Delivery.”Gene Therapy; 1999; vol. 6, pp. 643-650.
Murthy, Niren, Et al., “The Design and Synthesis of Polymers for Eukaryotic Membrane Disruption.”Journal of Controlled Release; 1999; vol. 61; pp. 137-143.
Netz, Roland R., Et al., “Complexation Behavior of Polyampholytes and Charged Objects.”Macromolecules; 1998; vol. 51; pp. 5123-5141.
Ogris, M., Et al., “PEGylated DNA/Transferrin-PEI Complexes: Reduced Interaction with Blood Components, Extended Circulation in Blood and Potential for Systemic Gene Delivery.”Gene Therapy; 1996; vol. 6; pp. 595-605.
Plank, Christian, Et al., “Activation of the Complement System by Synthetic DNA Complexes: A Potential Barrier for Intravenous Gene Delivery.”Human Gene Therapy; Aug. 1, 1996; vol. 7; pp. 1437-1446.
Ross, P.C., Et al., “Lipoplex Size is a Major Determinant of In Vitro Lipofection Efficiency.”Gene Therapy; 1999; vol. 6; pp. 651-659.
Trubetskoy, Vladimir S., “Layer-by-Layer Deposition of Oppositely Charged Polyelectrolytes on the Surface of Condensed DNA Particles.”Nucleic Acids Research; 1999; vol. 27, No. 15; pp. 3090-3095.
Vitiello, L., Et al., “Transfection of Cultured Myoblasts in High Serum Concentration with DODAC:DOPE Liposomes.”Gene Therapy; 1998; vol. 5; pp. 1306-1313.
Wolfert, Margreet A., Et al., “Characterization of Vectors for Gene Therapy Formed by Self-Assembly of DNA with Synthetic Block Co-Polymers.”Human Gene Therapy; Nov. 10, 1996; vol. 7; pp. 2123-2133.
Xu, Yuhong, Et al., “Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection.”Biochemistry; 1996; vol. 35, pp. 5616-5623.
Budker Vladimir G.
Hagstrom James E.
Trubetskoy Vladimir S.
Wolff Jon A.
Johnson Mark K.
Ketter James
Mirus Corporation
LandOfFree
Polyampholytes for delivering polyions to a cell does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polyampholytes for delivering polyions to a cell, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyampholytes for delivering polyions to a cell will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2864268